Emerald Mutual Fund Advisers Trust’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-903,231
Closed -$11.2M 241
2023
Q1
$11.2M Buy
903,231
+45,715
+5% +$841K 0.66% 71
2022
Q4
$16.5M Buy
857,516
+157,978
+23% +$3.34M 1.02% 41
2022
Q3
$13.1M Buy
+699,538
New +$14.4M 0.83% 51
2022
Q1
Sell
-363,273
Closed -$8.89M 209
2021
Q4
$8.89M Buy
363,273
+109,279
+43% +$2.57M 0.31% 98
2021
Q3
$5.92M Sell
253,994
-492,893
-66% -$11.9M 0.2% 112
2021
Q2
$20.5M Hold
746,887
0.67% 61
2021
Q1
$27.5M Buy
746,887
+567,993
+318% +$20.1M 0.91% 32
2020
Q4
$6.72M Hold
178,894
0.23% 115
2020
Q3
$3.9M Buy
+178,894
New +$3.76M 0.17% 115

Other funds holding AHCO

Emerald Mutual Fund Advisers Trust's AHCO Position: Q2 2023 in Review

Emerald Mutual Fund Advisers Trust sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 903,231 shares — an estimated $11.2M sold.

Emerald Mutual Fund Advisers Trust first reported a position in AHCO in Q3 2020 and held it in 9 quarters. The position peaked at $27.5M in Q1 2021. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • Emerald Mutual Fund Advisers Trust reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 903,231 AdaptHealth shares in Q2 2023, an estimated $11.2M.
  • Emerald Mutual Fund Advisers Trust first reported a position in AdaptHealth in Q3 2020 and held it in 9 quarters.
  • Emerald Mutual Fund Advisers Trust's AdaptHealth position peaked at $27.5M in Q1 2021.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2023, filed 10 Aug 2023.